Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER × Hyperprolactinemia × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 202 Neoplasms 128 Polycystic Ovary Syndrome 107 Carcinoma, Hepatocellular 81 Colorectal Neoplasms 76 Prostatic Neoplasms 70 Stomach Neoplasms 55 Lung Neoplasms 50 Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Carcinoma, Non-Small-Cell Lung 42 Pain, Postoperative 41 Pancreatic Neoplasms 40 Head and Neck Neoplasms 38 Pain 37 Liver Neoplasms 36 Leiomyoma 32 Leukemia, Myeloid, Acute 31 Keratosis, Actinic 31 Colonic Neoplasms 31 Recurrence 30 Neoplasm Metastasis 28 Multiple Myeloma 28 Infertility 28 Brain Neoplasms 28 Uterine Cervical Neoplasms 26 Urinary Bladder Neoplasms 24 Ovarian Neoplasms 24 Lymphoma 24 Esophageal Neoplasms 23 Papillomavirus Infections 21

Interventions

Dopamine Agonists 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡